HOXD-AS2 and central nervous system cancer: According to the expression of the HOXD-AS2 gene, 102 patients (the low-grade group included 45 patients with grade I–II glioma, and the high-grade group included 57 patients with grade III–IV glioma) were divided into a high-expression group and low-expression group.